Performance of the Self-administered Psoriasis Area and Severity Index in Evaluating Clinical and Sociodemographic Subgroups of Patients With Psoriasis
Open Access
- 1 March 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (3) , 353-358
- https://doi.org/10.1001/archderm.139.3.353
Abstract
IN CLINICAL practice, as well as in clinical research, it is important to objectively and accurately measure disease severity using standardized methods, both to compare different patients with different disease characteristics (discriminative properties) and to monitor the disease course within individual patients (evaluative properties).1,2Keywords
This publication has 12 references indexed in Scilit:
- Association of Dissatisfaction With Care and Psychiatric Morbidity With Poor Treatment ComplianceArchives of Dermatology, 2002
- Physical and psychologic measures are necessary to assess overall psoriasis severityJournal of the American Academy of Dermatology, 2001
- Psychiatric morbidity in dermatological outpatients: an issue to be recognizedBritish Journal of Dermatology, 2000
- Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their qualityBritish Journal of Dermatology, 1999
- The SAPASI Is Valid and Responsive to Psoriasis Disease Severity Changes in a Multi‐Center Clinical TrialThe Journal of Dermatology, 1999
- The Self-Administered Psoriasis Area and Severity Index Is Valid and ReliableJournal of Investigative Dermatology, 1996
- Measuring severity of psoriasis: methodological issuesJournal of Dermatological Treatment, 1996
- Patient Measurement of Psoriasis Disease Severity with a Structured InstrumentJournal of Investigative Dermatology, 1994
- Measuring health status: What are the necessary measurement properties?Journal of Clinical Epidemiology, 1992
- A methodological framework for assessing health indicesJournal of Chronic Diseases, 1985